Skip to content
Trial Eligibility
Menu

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

NCT07220967

This study is recruiting at 7 US sites in 2 states, according to its ClinicalTrials.gov record last updated .

Summary

The researchers are doing this study to find out whether Stimulan Rapid Cure works to reduce the risk of infections in people getting tissue expanders placed during mastectomy. The researchers will also study whether Stimulan Rapid Cure affects the risk of seroma, a possible complication of surgery that involves fluid buildup under the skin.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Breast Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
18 years and older
Sex
Female
Healthy volunteers
Not accepted
Sponsor
Memorial Sloan Kettering Cancer Center
Last updated on ClinicalTrials.gov
July 10, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New Jersey · 3

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) · Basking Ridge, NJ
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) · Middletown, NJ
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) · Montvale, NJ

New York · 4

  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) · Commack, NY
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities) · Harrison, NY
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites) · New York, NY
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites) · Rockville Centre, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.